What we expect European regulators to do in March 2024

BY CHELSEY MCINTYRE, PHARMD, KIRSTEN MESSMER, PHD, RAC, COREY JASEPH, MS, RAC, KARI OAKES

In this recurring feature, AgencyIQ, through public data and previous analysis, determines what European medicine and device regulators will likely do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods, and more. Given the expansive and complex European life sciences regulatory landscape, we’ll be including updates from key E.U. and national regulators. The goal: to allow regulatory professionals to better anticipate and prepare for upcoming events and catalysts.

Fill out the form to read the full article.

Required *

Copy link
Powered by Social Snap